PrognomiQ

PrognomiQ Raises $34M in Series D

PrognomiQ has successfully raised $34M in a Series D at a $180M valuation led by Seer, Casdin Capital.

Company Overview

PrognomiQ is a HealthTech company headquartered in San Mateo, CA, founded in 2019 with 80+ employees.

Healthcare company developing multi-cancer early detection tests

Fundraising Details

• Amount Raised: $34M
• Round Type: Series D
• Valuation: $180M
• Date: 2024-11-11
• Investors: Seer, Casdin Capital

About PrognomiQ

Healthcare company developing multi-cancer early detection tests The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

• Headquarters: San Mateo, CA
• Founded: 2019
• Team Size: 80+
• Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in PrognomiQ's vision and execution. The capital will likely be used to:

• Scale Operations: Expand the team and operational capacity
• Product Development: Enhance existing products and develop new features
• Market Expansion: Enter new markets and strengthen presence in existing ones
• Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. PrognomiQ's successful fundraising reflects the strong fundamentals and growth potential in this space.

Valuation Milestone

Reaching a $180M valuation marks an important milestone for PrognomiQ, positioning the company among notable players in the HealthTech industry.

Looking Ahead

With this new capital, PrognomiQ is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2024-11-11. For more information about PrognomiQ, visit their headquarters at San Mateo, CA.